Donate
Sign-in Local Events
Professionals



  1. FDA approves Kcentra for the urgent reversal of anticoagulation in adults with major bleeding
ACC 2011: EXCELLENT
  • Updated:Apr 5,2011
ACC11_Header2
EXCELLENT
The Randomized Comparison of Six-Month versus 12-Month Duration of Dual Antiplatelet Therapy after Implantation of Drug Eluting Stent: From Comparison of Everolimusversus Sirolimus-Eluting Stents for Coronary Revascularization (EXCELLENT) Trial
acc11_EXCELLENT_image Hyeon-Cheol Gwon, MD, PhD on behalf of EXCELLENT Investigators, Samsung Medical Center, Seoul, South Korea, Seoul National University Hospital, Seoul, South Korea





ACC11_AdBanner
 esc11_membership_iconesc11_mgam_iconesc11_ytc_iconss11_logo_icon
Join usSpread the word Become an advocateRegister today
esc11_pon_icon esc11_twitter_icon esc11_facebook_iconesc11_youtube_icon 
Join the conversation Follow @AHAScience Like us on Facebook Tune in
esc11_cvdaily_iconesc11_circ_ipad_iconesc11_stats_icon 
Subscribe nowCirculation for the iPadLearn more 

     

ACC 2011: Navigation
Science News from ACC 2011 - Home
Sunday, April 3
PARTNERPARTNER Cohort B
 
Monday, April 4
PRECOMBAT
EVEREST II
STICH
STICH Viability
RAPS		ISAR-CABG
RIVAL
RESOLUTE US
PLATINUM
REMEDIAL II
 
Tuesday, April 5
MAGELLAN
OSCAR
NAGOYA HEART Study
PROTECTION-AMI
EXCELLENT
 		TARGET Study
Rheos Trial
PROACT
AF Clinic
Danish Heart Failure Study
 
Science News Videos
Click on the link below to view complete video coverage from ACC 2011.  Plus, search all AHA/ASA Science news video archives.

acc11_sn_youtube2_button
 



 
Scientific Sessions 2012 SS12-Generic_280x280
 
Scientific Sessions scientificsessions_logo_2013_webheader

Scientific Sessions 2013
Scientific Sessions is the leading cardiovascular meeting in the country with over 17,000 professionals attending annually, and over 22,000 total attendees, as reported by the Healthcare Convention and Exhibitor’s Association. 

Dallas Convention Center
Dallas, Texas
Nov. 16–20, 2013